Your browser doesn't support javascript.
loading
Prognostic significance of haemodynamic parameters in patients with cardiogenic shock.
Berg, David D; Kaur, Gurleen; Bohula, Erin A; Baird-Zars, Vivian M; Alviar, Carlos L; Barnett, Christopher F; Barsness, Gregory W; Burke, James A; Chaudhry, Sunit-Preet; Chonde, Meshe; Cooper, Howard A; Daniels, Lori B; Dodson, Mark W; Gerber, Daniel A; Ghafghazi, Shahab; Gidwani, Umesh K; Goldfarb, Michael J; Guo, Jianping; Hillerson, Dustin; Kenigsberg, Benjamin B; Kochar, Ajar; Kontos, Michael C; Kwon, Younghoon; Lopes, Mathew S; Loriaux, Daniel B; Miller, P Elliott; O'Brien, Connor G; Papolos, Alexander I; Patel, Siddharth M; Pisani, Barbara A; Potter, Brian J; Prasad, Rajnish; Rowsell, Robert O; Shah, Kevin S; Sinha, Shashank S; Smith, Timothy D; Solomon, Michael A; Teuteberg, Jeffrey J; Thompson, Andrea D; Zakaria, Sammy; Katz, Jason N; van Diepen, Sean; Morrow, David A.
Afiliação
  • Berg DD; Levine Cardiac Intensive Care Unit, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Suite 7022, Boston, MA 02115, USA.
  • Kaur G; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Bohula EA; Levine Cardiac Intensive Care Unit, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Suite 7022, Boston, MA 02115, USA.
  • Baird-Zars VM; Levine Cardiac Intensive Care Unit, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Suite 7022, Boston, MA 02115, USA.
  • Alviar CL; Leon H Charney Division of Cardiology, Bellevue Hospital Center, New York University School of Medicine, New York, NY, USA.
  • Barnett CF; Division of Cardiology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Barsness GW; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
  • Burke JA; Division of Cardiology, Lehigh Valley Heart Network, Allentown, PA, USA.
  • Chaudhry SP; Department of Medicine, St Vincent Heart Center, Indianapolis, IN, USA.
  • Chonde M; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Cooper HA; Westchester Medical Center, New York Medical College, Valhalla, NY, USA.
  • Daniels LB; Division of Cardiovascular Medicine, Department of Medicine, University of California San Diego, La Jolla, CA, USA.
  • Dodson MW; Department of Pulmonary and Critical Care Medicine, Intermountain Medical Center, Murray, UT, USA.
  • Gerber DA; Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Ghafghazi S; Cardiovascular Medicine, University of Louisville, Louisville, KY, USA.
  • Gidwani UK; Division of Cardiology, Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Goldfarb MJ; Division of Cardiology, Jewish General Hospital, McGill University, Montreal, QC, Canada.
  • Guo J; Levine Cardiac Intensive Care Unit, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Suite 7022, Boston, MA 02115, USA.
  • Hillerson D; Department of Medicine, Division of Cardiovascular Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Kenigsberg BB; Departments of Cardiology and Critical Care, MedStar Washington Hospital Center, Washington, DC, USA.
  • Kochar A; Levine Cardiac Intensive Care Unit, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Suite 7022, Boston, MA 02115, USA.
  • Kontos MC; Division of Cardiology, Department of Medicine, Virginia Commonwealth University, Richmond, VA, USA.
  • Kwon Y; Division of Cardiology, University of Washington, Seattle, WA, USA.
  • Lopes MS; Levine Cardiac Intensive Care Unit, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Suite 7022, Boston, MA 02115, USA.
  • Loriaux DB; Division of Cardiology, Department of Medicine, Duke University, Durham, NC, USA.
  • Miller PE; Section of Cardiovascular Medicine, Yale University, New Haven, CT, USA.
  • O'Brien CG; Division of Cardiology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Papolos AI; Departments of Cardiology and Critical Care, MedStar Washington Hospital Center, Washington, DC, USA.
  • Patel SM; Levine Cardiac Intensive Care Unit, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Suite 7022, Boston, MA 02115, USA.
  • Pisani BA; Section of Cardiovascular Medicine, Department of Internal Medicine, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
  • Potter BJ; Cardiology Service, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM) Research Center and Cardiovascular Center, Montreal, QC, Canada.
  • Prasad R; Division of Cardiology, Wellstar Health System, Marietta, GA, USA.
  • Rowsell RO; Division of Cardiology, Lenox Hill Hospital, Northwell Health, Zucker School of Medicine, New York, NY, USA.
  • Shah KS; Division of Cardiology, Department of Medicine, University of Utah, Salt Lake City, UT, USA.
  • Sinha SS; Inova Heart and Vascular Institute, Inova Fairfax Medical Center, Falls Church, VA, USA.
  • Smith TD; Lindner Center for Research and Education, The Christ Hospital, Cincinnati, OH, USA.
  • Solomon MA; Critical Care Medicine Department, National Institutes of Health Clinical Center and Cardiovascular Branch, National Heart, Lung, and Blood Institute of the National Institutes of Health, Bethesda, MD, USA.
  • Teuteberg JJ; Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Thompson AD; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Zakaria S; Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Katz JN; Division of Cardiology, Department of Medicine, Duke University, Durham, NC, USA.
  • van Diepen S; Department of Critical Care Medicine and Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
  • Morrow DA; Levine Cardiac Intensive Care Unit, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Suite 7022, Boston, MA 02115, USA.
Eur Heart J Acute Cardiovasc Care ; 12(10): 651-660, 2023 Oct 25.
Article em En | MEDLINE | ID: mdl-37640029
ABSTRACT

AIMS:

Invasive haemodynamic assessment with a pulmonary artery catheter is often used to guide the management of patients with cardiogenic shock (CS) and may provide important prognostic information. We aimed to assess prognostic associations and relationships to end-organ dysfunction of presenting haemodynamic parameters in CS. METHODS AND

RESULTS:

The Critical Care Cardiology Trials Network is an investigator-initiated multicenter registry of cardiac intensive care units (CICUs) in North America coordinated by the TIMI Study Group. Patients with CS (2018-2022) who underwent invasive haemodynamic assessment within 24 h of CICU admission were included. Associations of haemodynamic parameters with in-hospital mortality were assessed using logistic regression, and associations with presenting serum lactate were assessed using least squares means regression. Sensitivity analyses were performed excluding patients on temporary mechanical circulatory support and adjusted for vasoactive-inotropic score. Among the 3603 admissions with CS, 1473 had haemodynamic data collected within 24 h of CICU admission. The median cardiac index was 1.9 (25th-75th percentile, 1.6-2.4) L/min/m2 and mean arterial pressure (MAP) was 74 (66-86) mmHg. Parameters associated with mortality included low MAP, low systolic blood pressure, low systemic vascular resistance, elevated right atrial pressure (RAP), elevated RAP/pulmonary capillary wedge pressure ratio, and low pulmonary artery pulsatility index. These associations were generally consistent when controlling for the intensity of background pharmacologic and mechanical haemodynamic support. These parameters were also associated with higher presenting serum lactate.

CONCLUSION:

In a contemporary CS population, presenting haemodynamic parameters reflecting decreased systemic arterial tone and right ventricular dysfunction are associated with adverse outcomes and systemic hypoperfusion.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Choque Cardiogênico / Hemodinâmica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Eur Heart J Acute Cardiovasc Care Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Choque Cardiogênico / Hemodinâmica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Eur Heart J Acute Cardiovasc Care Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos